Literature DB >> 19291117

Conservative management of ulcerated haemangioma--twenty years experience.

Anand Pandey1, Ajay Narayan Gangopadhyay, Shiv Prasad Sharma, Vijayendra Kumar, Saroj Chooramani Gopal, Dinesh Kumar Gupta.   

Abstract

Ulceration is the most common complication of haemangioma and occurs in 5-15% of cases. The present study was carried out to evaluate the clinical features of ulcerated haemangioma and efficacy of the management protocol adopted by us over a period of 20 years. All patients with ulcerated haemangioma were evaluated on the basis of age at presentation, sex, rural or urban distribution and site of haemangioma. Treatment included application of topical antibiotic and systemic antibiotic and analgesic for pain. The total number of patients was 608. The male to female ratio was 1: 2.28. The rural:urban distribution was 2.43:1. The most common site of involvement was head and neck. Mean age of patients was 5.60 +/- 2.44 months. Mean size of haemangioma and ulceration was 47.30 +/- 20.67 cm(2) and 7.49 +/- 4.52 cm(2), respectively. The mean time for ulcer healing was 40.06 +/- 19.41 days. Ulcer size of more than 10 cm(2) took more time to heal. Response to treatment was satisfactory. Ulcerated haemangioma usually occurs before completion of 1 year of age; hence, every patient with haemangioma needs careful attention. Adequate treatment and regular follow up brings satisfactory response in the patients.

Entities:  

Mesh:

Year:  2009        PMID: 19291117      PMCID: PMC7951731          DOI: 10.1111/j.1742-481X.2008.00562.x

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  15 in total

Review 1.  Guidelines of care for cutaneous haemangiomas.

Authors:  Y C Chan; Y C Giam
Journal:  Ann Acad Med Singapore       Date:  2005-01       Impact factor: 2.473

2.  Ulcerated hemangiomas: clinical characteristics and response to therapy.

Authors:  H J Kim; M Colombo; I J Frieden
Journal:  J Am Acad Dermatol       Date:  2001-06       Impact factor: 11.527

3.  Benign cutaneous vascular tumors of infancy: when to worry, what to do.

Authors:  D W Metry; A A Hebert
Journal:  Arch Dermatol       Date:  2000-07

Review 4.  PELVIS Syndrome.

Authors:  Céline Girard; Michèle Bigorre; Bernard Guillot; Didier Bessis
Journal:  Arch Dermatol       Date:  2006-07

5.  [Radiotherapy of ulcerated hemangioma].

Authors:  E L Podliashchuk
Journal:  Med Radiol (Mosk)       Date:  1983-12

6.  Response of ulcerated perineal hemangiomas of infancy to becaplermin gel, a recombinant human platelet-derived growth factor.

Authors:  Brandie J Metz; Melissa C Rubenstein; Moise L Levy; Denise W Metry
Journal:  Arch Dermatol       Date:  2004-07

7.  Efficacy of pulse dye laser therapy for the treatment of ulcerated haemangiomas: a review of 78 patients.

Authors:  Lisa R David; Marc M Malek; Louis C Argenta
Journal:  Br J Plast Surg       Date:  2003-06

8.  Multicenter prospective study of ulcerated hemangiomas.

Authors:  Sarah L Chamlin; Anita N Haggstrom; Beth A Drolet; Eulalia Baselga; Ilona J Frieden; Maria C Garzon; Kimberly A Horii; Anne W Lucky; Denise W Metry; Brandon Newell; Amy Jo Nopper; Anthony J Mancini
Journal:  J Pediatr       Date:  2007-08-24       Impact factor: 4.406

9.  Treatment of ulcerated hemangiomas with the pulsed tunable dye laser.

Authors:  J G Morelli; O T Tan; W L Weston
Journal:  Am J Dis Child       Date:  1991-09

10.  PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities.

Authors:  I J Frieden; V Reese; D Cohen
Journal:  Arch Dermatol       Date:  1996-03
View more
  3 in total

1.  How to Manage Disfiguring Scars in Involuted Infantile Hemangioma.

Authors:  Shunsuke Yuzuriha; Fumio Nagai; Masahiko Noguchi
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-06-06       Impact factor: 4.730

2.  Japanese clinical practice guidelines for vascular anomalies 2017.

Authors:  Hidefumi Mimura; Sadanori Akita; Akihiro Fujino; Masatoshi Jinnin; Mine Ozaki; Keigo Osuga; Hiroki Nakaoka; Eiichi Morii; Akira Kuramochi; Yoko Aoki; Yasunori Arai; Noriko Aramaki; Masanori Inoue; Yuki Iwashina; Tadashi Iwanaka; Shigeru Ueno; Akihiro Umezawa; Michio Ozeki; Junko Ochi; Yoshiaki Kinoshita; Masakazu Kurita; Shien Seike; Nobuyuki Takakura; Masataka Takahashi; Takao Tachibana; Kumiko Chuman; Shuji Nagata; Mitsunaga Narushima; Yasunari Niimi; Shunsuke Nosaka; Taiki Nozaki; Kazuki Hashimoto; Ayato Hayashi; Satoshi Hirakawa; Atsuko Fujikawa; Yumiko Hori; Kentaro Matsuoka; Hideki Mori; Yuki Yamamoto; Shunsuke Yuzuriha; Naoaki Rikihisa; Shoji Watanabe; Shinichi Watanabe; Tatsuo Kuroda; Shunsuke Sugawara; Kosuke Ishikawa; Satoru Sasaki
Journal:  Jpn J Radiol       Date:  2020-04       Impact factor: 2.374

3.  Japanese Clinical Practice Guidelines for Vascular Anomalies 2017.

Authors:  Hidefumi Mimura; Sadanori Akita; Akihiro Fujino; Masatoshi Jinnin; Mine Ozaki; Keigo Osuga; Hiroki Nakaoka; Eiichi Morii; Akira Kuramochi; Yoko Aoki; Yasunori Arai; Noriko Aramaki; Masanori Inoue; Yuki Iwashina; Tadashi Iwanaka; Shigeru Ueno; Akihiro Umezawa; Michio Ozeki; Junko Ochi; Yoshiaki Kinoshita; Masakazu Kurita; Shien Seike; Nobuyuki Takakura; Masataka Takahashi; Takao Tachibana; Kumiko Chuman; Shuji Nagata; Mitsunaga Narushima; Yasunari Niimi; Shunsuke Nosaka; Taiki Nozaki; Kazuki Hashimoto; Ayato Hayashi; Satoshi Hirakawa; Atsuko Fujikawa; Yumiko Hori; Kentaro Matsuoka; Hideki Mori; Yuki Yamamoto; Shunsuke Yuzuriha; Naoaki Rikihisa; Shoji Watanabe; Shinichi Watanabe; Tatsuo Kuroda; Shunsuke Sugawara; Kosuke Ishikawa; Satoru Sasaki
Journal:  J Dermatol       Date:  2020-03-22       Impact factor: 4.005

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.